...
首页> 外文期刊>World Journal of Gastroenterology >Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein
【24h】

Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein

机译:丙型肝炎病毒NS3 c末端缺失蛋白诱导的肝细胞转化和肿瘤发展

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the effect of hepatitis C virus nonstructural protein 3 c-terminal deleted protein (HCV NS3-5') on hepatocyte transformation and tumor development. METHODS: QSG7701 cells were transfected with plasmid pRcHCNS3-5' (expressing HCV NS3 c-terminal deleted protein) by lipofectamine and selected in G418. The expression of HCV NS3 gene and protein was determined by PCR and immunohistochemistry respectively. Biological behavior of transfected cells was observed through cell proliferation assay, anchorage-independent growth and tumor development in nude mice. The expression of HCV NS3 and c-myc proteins in the induced tumor was evaluated by immunohistochemistry. RESULTS: HCV NS3 was strongly expressed in QSG7701 cells transfected with plasmid pRcHCNS3-5' and the positive signal was located in cytoplasm. Cell proliferation assay showed that the population doubling time in pRcHCNS3-5' transfected cells was much shorter than that in pRcCMV and non-transfected cells (24 h, 26 h, 28 h respectively). The cloning ratio of cells transfected with pRcHCNS3-5', pRcCMV and non-transfected cells was 33 %, 1.46 %, 1.11 %, respectively, the former one was higher than that in the rest two groups (P<0.01). Tumor development was seen in nude mice inoculated with pRcHCNS3-5' transfected cells after 15 days. HE staining showed its feature of hepatocarcinoma, and immunohistochemistry confirmed the expressions of HCV NS3 and c-myc proteins in tumor tissue. The positive control group inoculated with HepG2 also showed tumor development, while no tumor developed in the nude mice injected with pRcCMV and non-transfected cells after 40 days. CONCLUSION: 1.HCV NS3 c-terminal deleted protein has transforming and oncogenic potential. 2. Human liver cell line QSG7701 may be used as a good model to study HCV NS3 pathogenesis.
机译:目的:研究丙型肝炎病毒非结构蛋白3 c-末端缺失蛋白(HCV NS3-5')对肝细胞转化和肿瘤发展的影响。方法:用脂质体转染脂蛋白转染QSG7701细胞,表达质粒pRcHCNS3-5'(表达HCV NS3 c末端缺失蛋白),并在G418中筛选。分别通过PCR和免疫组化方法检测HCV NS3基因和蛋白的表达。通过细胞增殖测定,不依赖锚定的生长和裸鼠的肿瘤发育观察到转染细胞的生物学行为。通过免疫组织化学评价HCV NS3和c-myc蛋白在诱导的肿瘤中的表达。结果:HCV NS3在质粒pRcHCNS3-5'转染的QSG7701细胞中强烈表达,阳性信号位于细胞质中。细胞增殖分析表明,pRcHCNS3-5'转染的细胞的群体倍增时间比pRcCMV和未转染的细胞的倍增时间短得多(分别为24 h,26 h,28 h)。 pRcHCNS3-5',pRcCMV和未转染细胞的克隆率分别为33%,1.46%,1.11%,前者高于其余两组(P <0.01)。 15天后,在接种了pRcHCNS3-5'转染的细胞的裸鼠中观察到肿瘤的发展。 HE染色显示其具有肝癌的特征,免疫组织化学证实了HCV NS3和c-myc蛋白在肿瘤组织中的表达。接种HepG2的阳性对照组也显示出肿瘤的发展,而注射pRcCMV和未转染细胞的裸鼠在40天后没有肿瘤的发展。结论:1.HCV NS3 c-末端缺失蛋白具有转化和致癌作用。 2.人肝细胞系QSG7701可作为研究HCV NS3发病机制的良好模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号